financetom
Business
financetom
/
Business
/
Brazil's Gerdau posts 9% fall in fourth-quarter profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil's Gerdau posts 9% fall in fourth-quarter profit
Feb 19, 2025 2:49 PM

SAO PAULO, Feb 19 (Reuters) - Brazilian steelmaker

Gerdau ( GGB ) reported on Wednesday a 9% decline in its

forth-quarter adjusted net profit from a year earlier, to total

666 million reais ($116.4 million).

The result came in below the 810.3 million reais profit

expected by analysts polled by LSEG.

($1 = 5.7214 reais)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Globant to Deploy AI Agents Across LaLiga Under New Agreement
Globant to Deploy AI Agents Across LaLiga Under New Agreement
Nov 7, 2025
07:18 AM EST, 11/07/2025 (MT Newswires) -- Globant ( GLOB ) said Friday it signed a memorandum of understanding with LaLiga to roll out agentic artificial intelligence across the Italian soccer league's operations. The effort will use Globant's ( GLOB ) subscription model of AI Pods, teams of software agents to accelerate development and productivity, the company said. Through Sportian,...
Array Digital Q3 Loss Narrows, Revenue Rises; New CEO Named
Array Digital Q3 Loss Narrows, Revenue Rises; New CEO Named
Nov 7, 2025
08:00 AM EST, 11/07/2025 (MT Newswires) -- Array Digital Infrastructure ( AD ) on Friday reported a Q3 loss of $0.44 per diluted share, narrower than a loss of $0.92 a year earlier. Two analysts polled by FactSet expected EPS of $0.30. Operating revenue for the quarter ended Sept. 30 was $47.1 million, up from $25.7 million a year earlier....
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Nov 7, 2025
Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in antibiotic-resistant skin infections caused by staph and strep infections, most commonly affecting childrenImpetigo affects approximately 3 million people in the U.S. every year and is among the most common bacterial skin infections seen...
Sylvamo Q3 Adjusted Earnings, Sales Fall
Sylvamo Q3 Adjusted Earnings, Sales Fall
Nov 7, 2025
07:18 AM EST, 11/07/2025 (MT Newswires) -- Sylvamo ( SLVM ) reported Q3 adjusted operating earnings Friday of $1.44 per diluted share, down from $2.44 a year earlier. Analysts' estimates were not readily available for comparison. Net sales for the quarter ended Sept. 30 were $846 million, compared with $965 million a year earlier. Three analysts surveyed by FactSet expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved